HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction.

AbstractOBJECTIVE:
To study insulin sensitivity and perfusion in skeletal muscle together with the beta-cell function in subjects with the m.3243A>G mutation in mitochondrial DNA, the most common cause of mitochondrial diabetes.
RESEARCH DESIGN AND METHODS:
We measured skeletal muscle glucose uptake and perfusion using positron emission tomography and 2-[18F]fluoro-2-deoxyglucose and [15O]H2O during euglycemic hyperinsulinemia in 15 patients with m.3243A>G. These patients included five subjects with no diabetes as defined by the oral glucose tolerance test (OGTT) (group 1), three with GHb <6.1% and newly found diabetes by OGTT (group 2), and seven with a previously diagnosed diabetes (group 3). Control subjects consisted of 13 healthy individuals who were similar to the carriers of m.3243A>G with respect to age and physical activity. Beta-cell function was assessed using the OGTT and subsequent mathematical modeling.
RESULTS:
Skeletal muscle glucose uptake was significantly lower in groups 1, 2, and 3 than in the control subjects. The glucose sensitivity of beta-cells in group 1 patients was similar to that of the control subjects, whereas in group 2 and 3 patients, the glucose sensitivity was significantly lower. The insulin secretion parameters correlated strongly with the proportion of m.3243A>G mutation in muscle.
CONCLUSIONS:
Our findings show that subjects with m.3243A>G are insulin resistant in skeletal muscle even when beta-cell function is not markedly impaired or glucose control compromised. We suggest that both the skeletal muscle insulin sensitivity and the beta-cell function are affected before the onset of the mitochondrial diabetes caused by the m.3243A>G mutation.
AuthorsMarkus M Lindroos, Kari Majamaa, Andrea Tura, Andrea Mari, Kari K Kalliokoski, Markku T Taittonen, Patricia Iozzo, Pirjo Nuutila
JournalDiabetes (Diabetes) Vol. 58 Issue 3 Pg. 543-9 (Mar 2009) ISSN: 1939-327X [Electronic] United States
PMID19073775 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Mitochondrial
  • Fluorine Radioisotopes
  • Hypoglycemic Agents
  • Insulin
  • Fluorodeoxyglucose F18
  • Guanine
  • Adenine
Topics
  • Adenine
  • Adult
  • DNA, Mitochondrial (genetics)
  • Diabetes Mellitus (genetics, physiopathology)
  • Female
  • Fluorine Radioisotopes
  • Fluorodeoxyglucose F18 (pharmacokinetics)
  • Glucose Clamp Technique
  • Guanine
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Insulin (physiology, therapeutic use)
  • Insulin-Secreting Cells (physiology)
  • Islets of Langerhans (physiopathology)
  • Male
  • Middle Aged
  • Muscle, Skeletal (physiology, physiopathology)
  • Polymorphism, Single Nucleotide
  • Positron-Emission Tomography
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: